Bimastat suspensija iekšķīgai lietošanai liellopiem
Bimastat suspensija iekšķīgai lietošanai liellopiem
Not authorised
- Sulfadiazine
- NEOMYCIN SULFATE
Product identification
Medicine name:
Bimastat suspensija iekšķīgai lietošanai liellopiem
Active substance:
- Sulfadiazine
- NEOMYCIN SULFATE
Target species:
-
Cattle (pre-ruminant)
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Sulfadiazine150.00/milligram(s)1.00millilitre(s)
-
NEOMYCIN SULFATE25.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Oral suspension
Withdrawal period by route of administration:
-
Oral use
-
Cattle (pre-ruminant)
-
Meat and offal28day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01RA02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Latvia
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Bimeda Animal Health Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- Bimeda Animal Health Limited
Responsible authority:
- Food And Veterinary Service
Authorisation number:
- V/NRP/11/0049
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 28/01/2025
Labelling
This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 28/01/2025
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 28/01/2025